No Access
EYE ON CHINA
https://doi.org/10.1142/S0219030318000186Cited by:0 (Source: Crossref)
Abstract
Shenzhen biotech companies building the world’s largest cell bank in Guizhou.
China’s cancer researcher shares 2018’s Sjoberg Prize of Sweden.
Breakthrough may help with earlier detection of heart attacks and cancer.
New dialyzer to isolate bacteria from unprocessed blood.
Chinese scientists develop new protocols for DNA-free genome editing in wheat.
Synthesized herbs to treat cardio-cerebrovascular disease.
Chinese scientists find antidote to centipede venom.
Grünenthal and Mundipharma enter commercial partnership in China.
Tencent and Medopad to cooperate on medical AI.
Majority of oncology clinical trials in China failed to meet enrolment targets.
WuXi STA and Regulus announce microRNA development and manufacturing collaboration.
Keywords:
- Cellular immunotherapy
- Guizhou Province
- CAR-T cell therapy
- Shenzhen biotech
- The Sjoberg Prize 2018
- The Royal Swedish Academy of Sciences
- biosensor
- optical microfiber coupler
- acute myocardial infarction
- dialyzer
- Chinese Academy of Sciences
- CRISPR/Cas9
- hexaploid wheat
- breviscapine
- cardiocerebrovascular disease
- Biosynthetic technology
- centipede venom
- retigabine
- tramadol
- medical AI
- oncology clinical trials
- microRNA
